Does RISANKIZUMAB-RZAA Cause Hypoaesthesia? 339 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 339 reports of Hypoaesthesia have been filed in association with RISANKIZUMAB-RZAA. This represents 0.5% of all adverse event reports for RISANKIZUMAB-RZAA.
339
Reports of Hypoaesthesia with RISANKIZUMAB-RZAA
0.5%
of all RISANKIZUMAB-RZAA reports
1
Deaths
109
Hospitalizations
How Dangerous Is Hypoaesthesia From RISANKIZUMAB-RZAA?
Of the 339 reports, 1 (0.3%) resulted in death, 109 (32.2%) required hospitalization, and 2 (0.6%) were considered life-threatening.
Is Hypoaesthesia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 339 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Hypoaesthesia?
ADALIMUMAB (7,423)
ETANERCEPT (4,497)
METHOTREXATE (4,175)
RITUXIMAB (3,605)
TOFACITINIB (3,324)
PREDNISONE (3,239)
TOCILIZUMAB (3,238)
FINGOLIMOD (3,180)
LENALIDOMIDE (3,127)
SECUKINUMAB (3,079)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Hypoaesthesia Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA